Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Approves Novel Treatment for UTIs
The FDA approved oral sulopenem etzadroxil and probenecid (Orlynvah) to treat uncomplicated urinary tract infections (uUTIs) caused by certain bacteria in women with limited or no alternative oral antibacterial treatment options, the agency said Friday.
US FDA approves Iterum's treatment for urinary infection
The U.S. Food and Drug Administration has approved Iterum Therapeutics' oral antibiotic to treat certain types of bacterial urinary tract infections (UTI) in adult women, the health regulator said on Friday.
Iterum Therapeutics Gets FDA Approval Of Orlynvah For Treatment Of Urinary Tract Infections
This is the first approved indication for Orlynvah and the first FDA-approved product for Iterum. "We are so pleased to have achieved this historic milestone and would like to thank all the patients,
Iterum Therapeutics Shares Soar on FDA's Orlynvah Approval
The clinical-stage pharmaceutical company said Friday that the Food and Drug Administration has approved its new drug application for Orlynvah as a treatment for uncomplicated urinary tract infections caused by certain microorganisms in adult women with limited or no alternative oral antibacterial treatment options.
Iterum stock rallies 54% on FDA approval of Orlynvah for UTIs
Iterum Therapeutics (NASDAQ:ITRM) stock shot up 54% Friday after the company received FDA approval for its drug Orlynvah for the treatment of uncomplicated urinary tract infections, or uUTIs. The drug,
Iterum Therapeutics Receives U.S. FDA Approval of ORLYNVAHâ„¢ (Oral Sulopenem) for the Treatment of Uncomplicated Urinary Tract Infections
ORLYNVAHâ„¢ is the first oral penem approved for use in the U.S. and the second FDA-approved treatment for uUTIs in the past two decades--Company
FiercePharma
9h
After prior rejection, Iterum nabs long-sought FDA nod for oral UTI drug Orlynvah
Despite recent concerns from the FDA about potential off-label use and antimicrobial resistance, Dublin-based Iterum ...
Reading Chronicle on MSN
19h
'My UTI turned out to be rare cancer - I thought I didn't have much time left'
Katie, a hairdresser by trade, said: "I had slight symptoms during the year but I put it down to a UTI. I had my anus and ...
dvm360
8h
Updates in management of urinary tract infections in small animal medicine
Veterinarians should become familiar with new definitions and recommendations for managing urinary tract infections in dogs ...
Verywell Health on MSN
15h
How Long Does a UTI Last?
Most people need antibiotics to treat a UTI, and these medications can clear up a UTI within 24-48 hours in most cases. If ...
infectiousdiseaseadvisor.com
10h
Gepotidacin Gets Priority Review for Uncomplicated UTI in Women
The FDA granted Priority Review to gepotidacin for the treatment of female adults and adolescents with uncomplicated UTI.
4h
Analyzing heart and kidney outcomes after canagliflozin treatment in older adults
Sodium-glucose co-transporter 2 (SGLT2) inhibitors reduce the risk of cardiovascular and kidney outcomes in patients with ...
22h
NT pharmacy services expanded to include UTI diagnosis and treatment
Pharmacists will be able to hand out antibiotics for urinary tract infections from Monday, marking the first condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback